| Year |
Citation |
Score |
| 2019 |
Baltussen R, Marsh K, Thokala P, Diaby V, Castro H, Cleemput I, Garau M, Iskrov G, Olyaeemanesh A, Mirelman A, Mobinizadeh M, Morton A, Tringali M, van Til J, Valentim J, ... Wagner M, et al. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 22: 1283-1288. PMID 31708065 DOI: 10.1016/J.Jval.2019.06.014 |
0.331 |
|
| 2019 |
Wagner M, Samaha D, Casciano R, Brougham M, Abrishami P, Petrie C, Avouac B, Mantovani L, Sarría-Santamera A, Kind P, Schlander M, Tringali M. Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study. International Journal of Health Policy and Management. 8: 424-443. PMID 31441279 DOI: 10.15171/Ijhpm.2019.24 |
0.342 |
|
| 2018 |
Wagner M, Samaha D, Cuervo J, Patel H, Martinez M, O'Neil WM, Jimenez-Fonseca P. Applying Reflective Multicriteria Decision Analysis (MCDA) to Patient-Clinician Shared Decision-Making on the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the Spanish Context. Advances in Therapy. PMID 29987525 DOI: 10.1007/S12325-018-0745-6 |
0.333 |
|
| 2018 |
Wagner M, Samaha D, Casciano R, Brougham M, Petrie C, Abrishami P, Avouac B, Kind P, Mantovani LG, Sarria-Santamera A, Schlander M, Tringali M. PP149 Features Of Accountable And Reasonable Processes For Coverage Decision-Making International Journal of Technology Assessment in Health Care. 34: 125-125. DOI: 10.1017/S0266462318002799 |
0.316 |
|
| 2018 |
Wagner M, Samaha D, Casciano R, Brougham M, Petrie C, Abrishami P, Avouac B, Kind P, Sarría-Santamera A, Schlander M, Mantovani L, Tringali M. Accountable and Reasonable Processes for Coverage Decision-Making for Rare Disease and Regenerative Therapies – Which Criteria Should be Considered and Why? Value in Health. 21. DOI: 10.1016/J.Jval.2018.04.437 |
0.317 |
|
| 2017 |
Wagner M, Samaha D, Khoury H, O'Neil WM, Lavoie L, Bennetts L, Badgley D, Gabriel S, Berthon A, Dolan J, Kulke MH, Goetghebeur M. Development of a Framework Based on Reflective MCDA to Support Patient-Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States. Advances in Therapy. PMID 29270780 DOI: 10.1007/S12325-017-0653-1 |
0.315 |
|
| 2017 |
Wagner M, Samaha D, O'Neil B, Khoury H, Bennetts L, Lavoie L, Badgley D, Gabriel S, Berthon A, Dinet J, Dolan J, Kulke M, Goetghebeur M. Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis Value in Health. 20. DOI: 10.1016/J.Jval.2017.08.2594 |
0.315 |
|
| 2016 |
Goetghebeur MM, Wagner M, Nikodem M, Zyla A, Micaleff A, Amzal B. Pragmatic Multicriteria Decision Analysis (MCDA) Combined With Advanced Pharmacoepidemiology for Benefit-Risk Assessments of Medicines Adapted to the Real-Life Constraints of Regulators: Development and Case Study. Therapeutic Innovation & Regulatory Science. 50: 620-631. PMID 30231761 DOI: 10.1177/2168479016642812 |
0.328 |
|
| 2016 |
Goetghebeur M, Samaha D, O'Neil B, Khoury H, Bennetts L, Lavoie L, Wagner M, Badgley D, Gabriel S, Berthon A, Dolan J, Kulke M. What Matters Most? An Exploration of Decision Criteria Considered by Patients with GEP-NET and Physicians Using Holistic Multi-Criteria Decision Analysis Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.233 |
0.322 |
|
| 2016 |
Goetghebeur M, Samaha D, Khoury H, O'Neil B, Lavoie L, Bennetts L, Wagner M, Badgley D, Gabriel S, Berthon A, Dolan J, Kulke M. To Treat or Watch? Identifying Drivers of Decisions for Patients with GEP-NET Using Reflective Multi-Criteria Decision Analysis Value in Health. 19. DOI: 10.1016/J.Jval.2016.09.223 |
0.327 |
|
| 2015 |
Wagner M, Khoury H, Willet J, Rindress D, Goetghebeur M. Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation. Pharmacoeconomics. PMID 26547306 DOI: 10.1007/S40273-015-0340-5 |
0.304 |
|
| 2014 |
Wagner M, Khoury H, Willet J, Rindress D, Goetghebeur M. Assessing The Value Of Treatments For Rare Diseases Using An Mcda-Based Approach: Methodological And Ethical Foundations Of Criteria Selection And Framework Development Value in Health. 17: A7. DOI: 10.1016/J.Jval.2014.03.046 |
0.306 |
|
| 2013 |
Tanios N, Wagner M, Tony M, Baltussen R, van Til J, Rindress D, Kind P, Goetghebeur MM. Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makers. International Journal of Technology Assessment in Health Care. 29: 456-65. PMID 24290340 DOI: 10.1017/S0266462313000573 |
0.346 |
|
| 2012 |
Guindo LA, Wagner M, Baltussen R, Rindress D, van Til J, Kind P, Goetghebeur MM. From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking. Cost Effectiveness and Resource Allocation : C/E. 10: 9. PMID 22808944 DOI: 10.1186/1478-7547-10-9 |
0.342 |
|
| 2012 |
Miot J, Wagner M, Khoury H, Rindress D, Goetghebeur MM. Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa. Cost Effectiveness and Resource Allocation : C/E. 10: 2. PMID 22376143 DOI: 10.1186/1478-7547-10-2 |
0.351 |
|
| 2012 |
Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 32: 376-88. PMID 21987539 DOI: 10.1177/0272989X11416870 |
0.343 |
|
| 2012 |
Tanios N, Wagner M, Tony M, Baltussen R, til JAV, Rindress D, Kind P, Goetghebeur MM. PHP139 Which Criteria are Considered in Health Care Decisions? Insights from an International Survey of Policy and Clinical Decision Makers Value in Health. 15. DOI: 10.1016/J.Jval.2012.08.681 |
0.308 |
|
| 2011 |
Tony M, Wagner M, Khoury H, Rindress D, Papastavros T, Oh P, Goetghebeur MM. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada. Bmc Health Services Research. 11: 329. PMID 22129247 DOI: 10.1186/1472-6963-11-329 |
0.331 |
|
| 2010 |
Goetghebeur MM, Wagner M, Khoury H, Rindress D, Grégoire JP, Deal C. Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patients. Cost Effectiveness and Resource Allocation : C/E. 8: 4. PMID 20377888 DOI: 10.1186/1478-7547-8-4 |
0.323 |
|
| 2009 |
Goetghebeur M, Wagner M, Khoury H, Rindress D, Grégoire J, Deal C. EE8 BRIDGING HEALTH TECHNOLOGY ASSESSMENT WITH MULTICRITERIA DECISION ANALYSIS (MCDA) AND AN ETHICAL FRAMEWORK FOR COMPLEX DECISIONS: CASE STUDY OF GROWTH HORMONE FOR TURNER SYNDROME Value in Health. 12: A230. DOI: 10.1016/S1098-3015(10)74123-1 |
0.315 |
|
| 2008 |
Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D. Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications. Bmc Health Services Research. 8: 270. PMID 19102752 DOI: 10.1186/1472-6963-8-270 |
0.307 |
|
| 2008 |
Goetghebeur M, Wagner M, Khoury H, Levitt R, Erickson L, Rindress D. PMC50 EVIDENCE ANDVALUE: IMPACT ON DECISION MAKING—THE EVIDEM FRAMEWORK AND POTENTIAL APPLICATIONS Value in Health. 11: A183-A184. DOI: 10.1016/S1098-3015(10)70584-2 |
0.324 |
|
| 2005 |
Wagner M, Nicell JA. Evaluation of Horseradish Peroxidase for the Treatment of Estrogenic Alkylphenols Water Quality Research Journal. 40: 145-154. DOI: 10.2166/Wqrj.2005.017 |
0.618 |
|
| 2003 |
Gehr R, Wagner M, Veerasubramanian P, Payment P. Disinfection efficiency of peracetic acid, UV and ozone after enhanced primary treatment of municipal wastewater. Water Research. 37: 4573-86. PMID 14568042 DOI: 10.1016/S0043-1354(03)00394-4 |
0.321 |
|
| 2003 |
Wagner M, Nicell JA. Impact of the presence of solids on peroxidase-catalyzed treatment of aqueous phenol Journal of Chemical Technology & Biotechnology. 78: 694-702. DOI: 10.1002/Jctb.754 |
0.622 |
|
| 2002 |
Wagner M, Nicell JA. Detoxification of phenolic solutions with horseradish peroxidase and hydrogen peroxide. Water Research. 36: 4041-52. PMID 12405413 DOI: 10.1016/S0043-1354(02)00133-1 |
0.601 |
|
| 2002 |
Wagner M, Brumelis D, Gehr R. Disinfection of wastewater by hydrogen peroxide or peracetic acid: development of procedures for measurement of residual disinfectant and application to a physicochemically treated municipal effluent. Water Environment Research : a Research Publication of the Water Environment Federation. 74: 33-50. PMID 11995865 DOI: 10.2175/106143002X139730 |
0.34 |
|
| 2002 |
Wagner M, Nicell JA. Impact of dissolved wastewater constituents on peroxidase-catalyzed treatment of phenol Journal of Chemical Technology & Biotechnology. 77: 419-428. DOI: 10.1002/Jctb.571 |
0.626 |
|
| 2001 |
Wagner M, Nicell JA. Peroxidase-catalyzed removal of phenols from a petroleum refinery wastewater. Water Science and Technology : a Journal of the International Association On Water Pollution Research. 43: 253-60. PMID 11380188 DOI: 10.2166/Wst.2001.0097 |
0.63 |
|
| 2001 |
Wagner M, Nicell JA. Treatment of a foul condensate from Kraft pulping with horseradish peroxidase and hydrogen peroxide. Water Research. 35: 485-95. PMID 11229003 DOI: 10.1016/S0043-1354(00)00276-1 |
0.628 |
|
| 1998 |
Buchanan ID, Nicell JA, Wagner M. Reactor Models for Horseradish Peroxidase–Catalyzed Aromatic Removal Journal of Environmental Engineering. 124: 794-802. DOI: 10.1061/(Asce)0733-9372(1998)124:9(794) |
0.617 |
|
| Show low-probability matches. |